The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.
about
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsRole of genetic polymorphisms in hepatitis C virus chronic infection.Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response.Diagnosis and treatment of hepatocellular carcinoma: An update.
P2860
The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The incidence and risk factors ...... erapy for chronic hepatitis C.
@en
The incidence and risk factors ...... erapy for chronic hepatitis C.
@nl
type
label
The incidence and risk factors ...... erapy for chronic hepatitis C.
@en
The incidence and risk factors ...... erapy for chronic hepatitis C.
@nl
prefLabel
The incidence and risk factors ...... erapy for chronic hepatitis C.
@en
The incidence and risk factors ...... erapy for chronic hepatitis C.
@nl
P2093
P1476
The incidence and risk factors ...... erapy for chronic hepatitis C.
@en
P2093
Akira Kawano
Hideyuki Nomura
Hirofumi Tanaka
Hirohisa Shigematsu
Hiromi Ishibashi
Kazufumi Dohmen
Kazuhiro Hayashida
Kazuhiro Takahashi
Kimihoko Yanagita
Masatora Haruno
P304
P577
2013-11-01T00:00:00Z